Latest filing published 15 Jul 2014 for FILANA THERAPEUTICS, INC., €429k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Grant Schoenhard: trading record in brief
All filings by Grant Schoenhard on record concern Filana Therapeutics, Inc. We count 26 filings; the first trade dates from 12 September 2008 and the latest from 11 July 2014.
The open-market side counts 2 purchases for €127k alongside 8 sales for €416k. Taken together, the sales exceed the purchases by €289k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants and 2 option exercises.
The newest entry dates from 15 July 2014: an option exercise of €429k, in Filana Therapeutics, Inc. The clock since the last published purchase (18 March 2010) now reads 6,080 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Grant Schoenhard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 128,693 shares@ US$4.54Common StockSEC:0001573723-14-000020:0
- 117,323 shares@ US$4.98Common StockSEC:0001573723-14-000020:1
- 650 shares@ US$1.92(1) Common StockSEC:0001573723-13-000003:0
- 11,032 shares0Common Stock (1)SEC:0001245261-12-000016:0
- 67,592 shares@ US$6.10Common StockSEC:0001245261-11-000005:0
- 60,280 shares@ US$6.84Common StockSEC:0001245261-11-000005:1
- 1,500 shares@ US$4.40Common StockSEC:0001245261-10-000032:0
- 1,500 shares@ US$5.54Common StockSEC:0001245261-10-000032:1
- 1,500 shares@ US$4.40Common StockSEC:0001245261-10-000029:0
- 1,500 shares@ US$5.45Common StockSEC:0001245261-10-000029:1
- 10,979 shares@ US$5.25Common StockSEC:0001245261-10-000023:0
- 10,979 shares@ US$5.74Common StockSEC:0001245261-10-000023:1
- 2,486 shares@ US$5.25Common StockSEC:0001245261-10-000022:0
- 2,486 shares@ US$5.77Common StockSEC:0001245261-10-000022:1
- 1,500 shares@ US$4.40Common StockSEC:0001245261-10-000021:0
- 3,609 shares@ US$5.25Common StockSEC:0001245261-10-000021:1
- 7,926 shares@ US$5.25Common StockSEC:0001245261-10-000021:2
- 5,109 shares@ US$5.75Common StockSEC:0001245261-10-000021:3
- 7,926 shares@ US$5.78Common StockSEC:0001245261-10-000021:4
- 1,500 shares@ US$4.40Common StockSEC:0001245261-10-000015:0
- 25,000 shares@ US$5.25Common StockSEC:0001245261-10-000015:1
- 26,500 shares@ US$6.29Common StockSEC:0001245261-10-000015:2
- 35,000 shares@ US$6.13Common StockSEC:0001245261-10-000010:2
- 10,000 shares@ US$4.40Common StockSEC:0001245261-10-000010:0Canonical exit: 14 Jun 2010 (T+90)
- 25,000 shares@ US$5.25Common StockSEC:0001245261-10-000010:1Canonical exit: 14 Jun 2010 (T+90)
25 of 26 declarations